A Longitudinal Study of Abnormalities on MRI and Disability from Multiple Sclerosis

Cited by (858)

Items 301–400 of 858

1. Characterizing Clinical and MRI Dissociation in Patients with Multiple Sclerosis
   Brian C. Healy, Guy J. Buckle, Eman Nassim Ali, Svetlana Egorova, Fariha Khalid, Shahamat Tauhid, Bonnie I. Glanz, Tanuja Chitnis, Charles R.G. Guttmann, Howard L. Weiner et al. · 2017 · Journal of Neuroimaging
2. Management of optic neuritis and impact of clinical trials: An international survey
   Valérie Biousse, Olivier Calvetti, Carolyn Drews‐Botsch, Edward J. Atkins, Busaba Sathornsumetee, Nancy J. Newman · 2008 · Journal of the Neurological Sciences
3. Interferon-β in the treatment of relapsing–remitting multiple sclerosis
   Michel Revel · 2003 · Pharmacology & Therapeutics
4. Optic neuritis: A mechanistic view
   Erik V. Burton, Benjamin M. Greenberg, Elliot M. Frohman · 2010 · Pathophysiology
5. The risk of relapse after a clinically isolated syndrome is related to the pattern of oligoclonal bands
   Isabel Boscá, M.J. Magraner, Francisco Coret, J. C. Alvarez‐Cermeño, María Simó, Luisa María Villar, Bonaventura Casanova · 2010 · Journal of Neuroimmunology
6. Specificity of Barkhof Criteria in Predicting Conversion to Multiple Sclerosis When Applied to Clinically Isolated Brainstem Syndromes
   Jaume Sastre‐Garriga, Mar Tintoré, Àlex Rovira, Carlos Nos, Jordi Río, Alan J. Thompson, Xavier Montalbán · 2004 · Archives of Neurology
7. The transition from relapsing-remitting MS to irreversible disability: clinical evaluation
   María Trojano, Damiano Paolicelli, Alessandra Bellacosa, Stefania Cataldo · 2003 · Neurological Sciences
8. Spontaneous MxA mRNA level predicts relapses in patients with recently diagnosed MS
   Laura F. van der Voort, Anke Vennegoor, Allerdien Visser, Dirk Lucas Knol, Bernard M.J. Uitdehaag, Frederik Barkhof, Cees B.M. Oudejans, Chris H. Polman, Joep Killestein · 2010 · Neurology
9. Serum anti-GAGA4 IgM antibodies differentiate relapsing remitting and secondary progressive multiple sclerosis from primary progressive multiple sclerosis and other neurological diseases
   Johannes Brettschneider, Troy D. Jaskowski, Hayrettin Tumani, Sana Abdul, Dee Husebye, Haniah Seraj, Harry R. Hill, Ella Fire, Larissa Spector, Jennifer Yarden et al. · 2009 · Journal of Neuroimmunology
10. In vivo quantitative evaluation of brain tissue damage in multiple sclerosis using gradient echo plural contrast imaging technique
    Pascal Sati, Anne Haney Cross, Jie Luo, Charles F. Hildebolt, Dmitriy A. Yablonskiy · 2010 · NeuroImage
11. Magnetic Resonance Imaging Predictors of Conversion to Multiple Sclerosis in the BENEFIT Study
    Bastiaan Moraal, Christoph Pohl, Bernard M.J. Uitdehaag, Chris H. Polman, Gilles Edan, Mark S. Freedman, Hans‐Peter Hartung, Ludwig Kappos, David H. Miller, Xavier Montalbán et al. · 2009 · Archives of Neurology
12. Cerebrospinal fluid levels of brain specific proteins in optic neuritis
    E T Lim, Donna Grant, Mikhail V. Pashenkov, Geoffrey Keir, E J Thompson, Mats B. Söderström, Gavin Giovannoni · 2004 · Multiple Sclerosis Journal
13. Downregulation of VLA-4 on T cells as a marker of long term treatment response to interferon beta-1a in MS
    Merja Soilu‐Hänninen, Mikko Laaksonen, Arno L. M. Hänninen, Juha-Pekka Erälinna, Martin Panelius · 2005 · Journal of Neuroimmunology
14. Histogram analysis of diffusion measures in clinically isolated syndromes and relapsing-remitting multiple sclerosis
    Chunshui Yu, Fuchun Lin, Yaou Liu, Yunyun Duan, Hao Chuan Lei, Kun Cheng Li · 2007 · European Journal of Radiology
15. Disease-modifying therapies for multiple sclerosis
    John R. Corboy, Douglas S. Goodin, Elliot M. Frohman · 2003 · Current Treatment Options in Neurology
16. Magnetization transfer magnetic resonance imaging and clinical changes in patients with relapsing-remitting multiple sclerosis.
    C. Oreja-Guevara, Arnaud Charil, D. Caputo, R. Cavarretta, M. Sormani, M. Filippi · 2006 · Archives of Neurology
17. Multiple sclerosis: an update for oral health care providers
    Dena J. Fischer, Joel Brian Epstein, Gary D. Klasser · 2009 · Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology
18. Clinical and conventional MRI predictors of disability and brain atrophy accumulation in RRMS
    Šarlota Mesaroš, Maria Assunta Rocca, Maria Pia Sormani, Arnaud Charil, G. Comi, Massimo Filippi · 2008 · Journal of Neurology
19. Acute transverse myelitis with normal brain MRI
    Jui Perumal, Rana Zabad, Christina Caon, Megan MacKenzie, Alexandros C. Tselis, Fen Bao, Zahid Latif, Imad Zak, Robert P. Lisak, Omar Khan · 2007 · Journal of Neurology
20. Disease-modifying drugs for multiple sclerosis: current and future aspects
    Mark Steven Freedman · 2006 · Expert Opinion on Pharmacotherapy
21. The utility of multimodal evoked potentials in multiple sclerosis prognostication.
    S. Ramanathan, Kerry Lenton, T. Burke, L. Gomes, Karen Storchenegger, C. Yiannikas, S. Vucic · 2013 · Journal of clinical neuroscience
22. Systemic T-cell activation in acute clinically isolated optic neuritis
    Hanne Roed, Jette Lautrup Frederiksen, Annika Reynberg Langkilde, Torben Lykke Sørensen, Martin Lauritzen, Finn Thorup Sellebjerg · 2005 · Journal of Neuroimmunology
23. Axonal loss is progressive and partly dissociated from lesion load in early multiple sclerosis
    Ana María Jiménez Pascual, M. Carmen Martínez‐Bisbal, Isabel Boscá, Carlos E. Calderon Valero, Francisco Coret, Beatriz Martínez-Granados, Luis Martí‐Bonmatí, Anis Khusro Mir, Bernardo Celda, Bonaventura Casanova · 2007 · Neurology
24. Anti-Inflammatory Effects of FTY720 Do Not Prevent Neuronal Cell Loss in a Rat Model of Optic Neuritis
    Christian R. Rau, Katharina Hein, Muriel B. Sättler, Benedikt Kretzschmar, Carina Hillgruber, Bradford L. McRae, Ricarda Diem, Mathias Bähr · 2011 · American Journal Of Pathology
25. Pattern Recognition of the Multiple Sclerosis Syndrome
    Rana Zabad, Renee Stewart, Kathleen M. Healey · 2017 · Brain Sciences
26. Using personalized prognosis in the treatment of relapsing multiple sclerosis: A practical guide
    Bart V Wijmeersch, Hans‐Peter Hartung, Patrick Vermersch, Maura Pugliatti, Carlo Pozzilli, Nikolaos Grigoriadis, Mona Marwan Alkhawajah, Laura M. Airas, Ralf Andreas Linker, Celia Oreja‐Guevara · 2022 · Frontiers in Immunology
27. Predictive Value of Imaging Markers at Multiple Sclerosis Disease Onset Based on Gadolinium- and USPIO-Enhanced MRI and Machine Learning
    Alessandro Crimi, Olivier Commowick, Adil Maarouf, Jean‐Christophe Ferré, Élise Bannier, Ayman Tourbah, I. Berry, Jean‐Philippe Ranjeva, Gilles Edan, Christian Barillot · 2014 · PLoS ONE
28. Magnetic Resonance Imaging of Multiple Sclerosis
    Massimo Filippi, Carla Tortorella, Marco Rovaris · 2002 · Journal of Neuroimaging
29. Risk of multiple sclerosis after optic neuritis in patients with normal baseline brain MRI
    Inês Brás Marques, Fernando Matias, Eduardo Duarte Silva, Luı́s Cunha, Lívia Sousa · 2013 · Journal of Clinical Neuroscience
30. Unilateral motor progression in MS
    Elia Sechi, B. Mark Keegan, Timothy J. Kaufmann, Orhun H. Kantarci, Brian G. Weinshenker, Eoin P. Flanagan · 2019 · Neurology
31. Approaches to the Management of Agents Used for the Treatment of Multiple Sclerosis: Consensus Statements from a Panel of U.S. Managed Care Pharmacists and Physicians
    Ross M. Miller, Laura E. Happe, Kellie L. Meyer, Rachel J. Spear · 2012 · Journal of Managed Care Pharmacy
32. Serum elements and oxidative status in clinically isolated syndromes
    Giovanni Ristori, Sonia Brescianini, Anna Pino, A. Visconti, D. Vittori, Giulia Coarelli, Rodolfo Cotichini, Beatrice Bocca, Giovanni Forte, Carlo Pozzilli et al. · 2011 · Neurology
33. Unfolding the long-term pathophysiological processes following an acute inflammatory demyelinating lesion of multiple sclerosis
    Wafaa Zaaraoui, Audrey Rico, Bertrand Audoin, Françoise Reuter A, Irina Malikova A, Elisabeth Soulier, Patrick Viout, Yann Le Fur, Sylviane Confort-gouny A, Patrick J. Cozzone et al. · 2010 · Magnetic Resonance Imaging
34. Intrathecal synthesis of IgM measured after a first demyelinating event suggestive of multiple sclerosis is associated with subsequent MRI brain lesion accrual
    Laurence Durante, Wafaa Zaaraoui, Audrey Rico, Lydie Crespy, Delphine Wybrecht, Anthony Faivre, Françoise Reuter A, Irina Malikova A, Gilbert J. Pommier, Sylviane Confort-gouny A et al. · 2011 · Multiple Sclerosis Journal
35. Acquired inflammatory white matter diseases
    Michele Gallucci, Massimo Caulo, Gabriella Cerone, Carlo Masciocchi · 2001 · Child s Nervous System
36. Early magnetic resonance imaging predictors of clinical progression after 48 months in clinically isolated syndrome patients treated with intramuscular interferon β‐1a
    Tomáš Uher, Dana Horáková, Tomáš Kalinčík, Niels Bergsland, Michaela Týblová, Deepa Preeti Ramasamy, Zdeněk Seidl, Manuela Vaněčková, Jan Krásenský, Eva Havrdová et al. · 2015 · European Journal of Neurology
37. Immunomodulatory treatment strategies in multiple sclerosis
    Bernd C. Kieseier, Heinz Wiendl, Verena Isabell Leussink, Olaf Stüve · 2008 · Journal of Neurology
38. A widespread pattern of cortical activations in patients at presentation with clinically isolated symptoms is associated with evolution to definite multiple sclerosis.
    Maria Assunta Rocca, Domenico Maria Mezzapesa, Angelo Ghezzi, Andrea Falini, Vittorio Martinelli, Giuseppe Scotti, Giancarlo Comi, Massimo Filippi · 2005 · PubMed Central
39. Multiple paradigm shifts in multiple sclerosis
    Bernd C. Kieseier, Hans‐Peter Hartung · 2003 · Current Opinion in Neurology
40. Is the frequency of abnormalities on magnetic resonance imaging in isolated optic neuritis related to the prevalence of multiple sclerosis? A global comparison
    Josephine K. Swanton · 2006 · Journal of Neurology Neurosurgery & Psychiatry
41. Exploring the heterogeneity of MS lesions using positron emission tomography: a reappraisal of their contribution to disability
    Bruno Stankoff, Émilie Poirion, Mattéo Tonietto, Benedetta Bodini · 2018 · Brain Pathology
42. Progressive motor impairment from a critically located lesion in highly restricted CNS-demyelinating disease
    B. Mark Keegan, Timothy J. Kaufmann, Brian G. Weinshenker, Orhun H. Kantarci, William F. Schmalstieg, M. Mateo Paz Soldán, Eoin P. Flanagan · 2018 · Multiple Sclerosis Journal
43. New immunopathologic insights into multiple sclerosis
    B. Hemmer, B. Kieseier, S. Cepok, H. Hartung · 2003 · Current Neurology and Neuroscience Reports
44. Lessons from 10 years of interferon beta-1b (Betaferon�/Betaseron�) treatment
    Antonios Bayas, Ralf Gold · 2003 · Journal of Neurology
45. Incidence and factors associated with treatment failure in the CLIMB multiple sclerosis cohort study
    Susan A. Gauthier, Bonnie I. Glanz, Micha Mandel, Antonios Tsagkaropoulos, Mohit Neema, James M. Stankiewicz, Ashish Arora, Yang Duan, Zsuzsanna Liptak, Svetlana Egorova et al. · 2009 · Journal of the Neurological Sciences
46. Predictors of Conversion to Multiple Sclerosis in Patients with Clinical Isolated Syndrome Using the 2010 Revised McDonald Criteria
    Alroughani, R., Al Hashel, J., Lamdhade, S., Ahmed, S. F. · 2012 · ISRN Neurology
47. Prognosis of multiple sclerosis: clinical factors predicting the late evolution for an early treatment decision
    Roberto Bergamaschi · 2006 · Expert Review of Neurotherapeutics
48. Natural History of Multiple Sclerosis: Early Prognostic Factors
    Ellen M. Mowry · 2011 · Neurologic Clinics
49. No prognostic value of routine cerebrospinal fluid biomarkers in a population-based cohort of 407 multiple sclerosis patients
    Madlyne Becker, Clotilde Latarche, Emilie Román, Marc Debouverie, Catherine Malaplate, Françis Guillemin · 2015 · BMC Neurology
50. Multiple Sclerosis and the Cerebellum
    Leticia Tornes, Brittani L. Conway, William A. Sheremata · 2014 · Neurologic Clinics
51. Vitamin D supplementation in multiple sclerosis: an expert opinion based on the review of current evidence
    Robin Boltjes, Stephanie A. M. Knippenberg, Oliver H.H. Gerlach, Raymond Hupperts, Jan G.M.C. Damoiseaux · 2021 · Expert Review of Neurotherapeutics
52. Incidental demyelinating inflammatory lesions in asymptomatic patients: a Brazilian cohort with radiologically isolated syndrome and a critical review of current literature
    Antônio Carlos Martins Maia, Antônio José da Rocha, Bernardo Rodi Barros, Charles Peter Tilbery · 2012 · Arquivos de Neuro-Psiquiatria
53. Whole‐brain 3 D FLAIR at 7 T using direct signal control
    Arian Beqiri, Hans M. Hoogduin, Alessandro Sbrizzi, Joseph V. Hajnal, Shaihan Malik · 2018 · Magnetic Resonance in Medicine
54. Demyelinating Disorders of the Central Nervous System
    I. Pirko, J. Noseworthy · 2009 · Textbook of Clinical Neurology
55. Treatment optimization in multiple sclerosis: report of an international consensus meeting
    International Working Group for Treatment Optimization in MS · 2003 · European Journal of Neurology
56. Multiple sclerosis and pregnancy
    Mary D. Hughes · 2004 · Neurologic Clinics
57. A prospective observational safety study on MF59® adjuvanted cell culture-derived vaccine, Celtura® during the A/H1N1 (2009) influenza pandemic
    Humberto Reynales, Pedro Astudillo, Serge De Vallière, Christoph Hatz, Patricia Schlagenhauf, Barbara A. Rath, Priscilla Velentgas, Ariel Fariña, Victor Sales-Carmona, Nicola Groth · 2012 · Vaccine
58. The optic nerve should be included as one of the typical CNS regions for establishing dissemination in space when diagnosing MS – Yes
    Steven L. Galetta, Laura Joan Balcer · 2017 · Multiple Sclerosis Journal
59. Natural Course of Clinically Isolated Syndrome: A Longitudinal Analysis Using a Markov Model
    Yuli Hou, Yujuan Jia, Jing-Tian Hou · 2018 · Scientific Reports
60. Non-conventional MRI techniques for measuring neuroprotection, repair and plasticity in multiple sclerosis
    Paul Steven Giacomini, Douglas Lorne Arnold · 2008 · Current Opinion in Neurology
61. Consensus guidelines for the diagnosis and treatment of multiple sclerosis
    Yamout, B., Alroughani, R., Al-Jumah, M., Khoury, S., Abouzeid, N., Dahdaleh, M., Alsharoqi, I., Inshasi, J., Hashem, S., Zakaria, M. et al. · 2013 · Current Medical Research and Opinion
62. The clinical perspective: How to personalise treatment in MS and how may biomarkers including imaging contribute to this?
    Patrick Vermersch, Thomas Berger, Ralf Gold, Carsten Lukas, Àlex Rovira, Bianca Meesen, Declan Chard, Manuel Comabella, Jacqueline A. Palace, María Trojano · 2016 · Multiple Sclerosis Journal
63. Consensus statement on the treatment of multiple sclerosis by the Spanish Society of Neurology in 2016
    A. García Merino, J.R. Ara, Óscar Fernández, Lamberto Landete Pascual, E. Moral Torres, A. Rodríguez-Antigüedad Zarrantz · 2017 · Neurología (English Edition)
64. Monthly brain magnetic resonance imaging scans in patients with clinically isolated syndrome
    Isabella Ferdinanda Pestalozza, Carlo Pozzilli, Silvia Di Legge, Maria Cristina Piattella, Patrizià Pantano, Francesca Caramia, Patrizio Pasqualetti, G. L. Lenzi · 2005 · Multiple Sclerosis Journal
65. The ependymal "Dot-Dash" sign: an MR imaging finding of early multiple sclerosis.
    Christopher J. Lisanti, Patrick Asbach, William G. Bradley · 2005 · PubMed Central
66. Novel composite MRI scale correlates highly with disability in multiple sclerosis patients
    Peter F. Kosa, Mika Komori, Ryan S. Waters, Tianxia Wu, Irene C. M. Cortese, Joan M. Ohayon, Kaylan M. Fenton, Jamie Cherup, Tomáš Gedeon, Bibiana Bielekova · 2015 · Multiple Sclerosis and Related Disorders
67. Multiple sclerosis lesions: insights from imaging techniques
    Valentina Tomassini, Jacqueline A. Palace · 2009 · Expert Review of Neurotherapeutics
68. Assessment of Disability Progression Independent of Relapse and Brain MRI Activity in Patients with Multiple Sclerosis in Poland
    Katarzyna Kapica-Topczewska, François Collin, Joanna Tarasiuk, Agata Czarnowska, Monika Chorąży, Anna Mirończuk, Jan Kochanowicz, Alina Kułakowska · 2021 · Journal of Clinical Medicine
69. Insights from magnetic resonance imaging
    Massimo Filippi, Arnaud Charil, Marco Rovaris, Martina Absinta, Maria Assunta Rocca · 2014 · Handbook of clinical neurology
70. Prognostic factors for long-term outcomes in relapsing–remitting multiple sclerosis
    Anthony L. Traboulsee, Peter Cornelissea, Magnhild Sandberg‐Wollheim, Bernard M.J. Uitdehaag, Ludwig Kappos, Peter Joseph Jongen, Cris S. Constantinescu, Elisabetta Verdun di Cantogno, David K.B. Li · 2016 · Multiple Sclerosis Journal - Experimental Translational and Clinical
71. Interferons in multiple sclerosis: Ten years' experience
    Ayman Tourbah, Olivier Lyon‐Caen · 2007 · Biochimie
72. Multiple sclerosis trial designs for the 21st century: Building on recent lessons
    FRED D. LUBLIN · 2005 · Journal of Neurology
73. Action of treosulfan in myelin-oligodendrocyte-glycoprotein-induced experimental autoimmune encephalomyelitis and human lymphocytes
    Robert Weissert, Heinz Wiendl, Heike Pfrommer, Maria K. Storch, Bettina Schreiner, Silvia Barth, Thomas Seifert‐Held, Arthur Melms, JOHANNES DICHGANS, Michael Weller · 2003 · Journal of Neuroimmunology
74. Advances in Multiple Sclerosis and its Variants
    Timothy Ryan Miller, Suyash Mohan, Asim F. Choudhri, Dheeraj Gandhi, Gaurav Jindal · 2014 · Radiologic Clinics of North America
75. Early prognosis of multiple sclerosis
    Josephine K. Swanton, Kryshani Fernando, David H. Miller · 2014 · Handbook of clinical neurology
76. Early treatment and dose optimisation
    Hans‐Peter Hartung · 2005 · Journal of Neurology
77. Comparison of 3D Cube FLAIR with 2D FLAIR for Multiple Sclerosis Imaging at 3 Tesla
    Maximilian Patzig, Michael Burke, H. Brückmann, Gunther Fesl · 2013 · RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren
78. Nonconventional Optic Nerve Imaging in Multiple Sclerosis
    Christopher C. Glisson, Steven L. Galetta · 2008 · Neuroimaging Clinics of North America
79. The association of intrathecal immunoglobulin synthesis and cortical lesions predicts disease activity in clinically isolated syndrome and early relapsing–remitting multiple sclerosis
    Massimiliano Calabrese, Lisa Federle, Valentina Bernardi, Francesca Rinaldi, Alice Favaretto, Mariacristina Varagnolo, Paola Perini, Mario Plebani, Paolo Gallo · 2011 · Multiple Sclerosis Journal
80. SUMMIT (Serially Unified Multicenter Multiple Sclerosis Investigation): creating a repository of deeply phenotyped contemporary multiple sclerosis cohorts
    Riley M. Bove, Tanuja Chitnis, Bruce Cree, Mar Tintoré, Yvonne Naegelin, Bernard M.J. Uitdehaag, Ludwig Kappos, Samia Joseph Khoury, Xavier Montalbán, Stephen L. Hauser et al. · 2017 · Multiple Sclerosis Journal
81. MRI criteria in MS patients with negative and positive oligoclonal bands: equal fulfillment of Barkhof’s criteria but different lesion patterns
    Hagen Bernhard Huttner, Peter Dieter Schellinger, Tobias Struffert, Gregor Richter, Tobias Engelhorn, Teresa Bassemir, Mathias Mäurer, Meritxell Garcia, Stefan Schwab, Martin Köhrmann et al. · 2009 · Journal of Neurology
82. Knowledge, attitude and practices regarding tuberculosis and dots among interns in delhi, India.
    Sanjay Rajpal, Anshu Mittal, V K Dhingra, Rahul Malhotra, Rajni Gupta, Chetna Malhotra, D K Taneja · 2007 · PubMed
83. Principles of a new treatment algorithm in multiple sclerosis
    Hans‐Peter Hartung, Xavier Montalbán, Per Soelberg Sørensen, Patrick Vermersch, Tomas P Olsson · 2011 · Expert Review of Neurotherapeutics
84. Hearing Ability and Its Relationship with Psychosocial Health, Work-Related Variables, and Health Care Use: The National Longitudinal Study on Hearing
    Janneke Nachtegaal, Joost Μ. Festen, Sophia E. Kramer · 2011 · Audiology Research
85. Pronounced focal and diffuse brain damage predicts short-term disease evolution in patients with clinically isolated syndrome suggestive of multiple sclerosis
    Emilia Sbardella, Valentina Tomassini, Maria Laura Stromillo, Nicola Filippini, Marco Battaglini, Serena Ruggieri, Luca Ausili Cefaro, Eytan Raz, Claudio Gasperini, Maria Pia Sormani et al. · 2011 · Multiple Sclerosis Journal
86. Comparative Study of the Presence of Chlamydia pneumoniae in Cerebrospinal Fluid of Patients with Clinically Definite and Monosymptomatic Multiple Sclerosis
    Subramaniam Sriram, Song‐Yi Yao, Charles W. Stratton, Peter A. Calabresi, William Marvin Mitchell, Hideaki Ikejima, Yoshimasa Yamamoto · 2002 · Clinical and Vaccine Immunology
87. Prognostic relevance of MRI in early relapsing multiple sclerosis: ready to guide treatment decision making?
    Olaf Martin Hoffmann, Ralf Gold, Sven Guenther Meuth, Ralf Andreas Linker, Thomas Skripuletz, Heinz Wiendl, Mike Peter Wattjes · 2024 · Therapeutic Advances in Neurological Disorders
88. Predictive MRI Biomarkers in MS—A Critical Review
    Vlad Eugen Tiu, Iulian Ion Enache, Cristina Panea, Cristina Tiu, Bogdan Ovidiu Popescu · 2022 · Medicina
89. MRI characteristics are predictive for CDMS in monofocal, but not in multifocal patients with a clinically isolated syndrome
    Jessica M. Nielsen, Christoph Pohl, Chris H. Polman, Frederik Barkhof, Mark S. Freedman, Gilles Edan, David H. Miller, Lars Bauer, Rupert Sandbrink, Ludwig Kappos et al. · 2009 · BMC Neurology
90. Early anisotropy changes in the corpus callosum of patients with optic neuritis
    Maxim Bester, Christoph Heesen, Sven Schippling, Roland Martinꝉ, Xiaoqi Q. Ding, Brigitte Holst, Jens Fiehler · 2008 · Neuroradiology
91. Emergency Diagnosis of Subarachnoid Hemorrhage: An Evidence-Based Debate
    Ali Farzad, Bethany Radin, Jason S. Oh, Heidi M. Teague, Brian D. Euerle, Jose Victor Nable, Aisha T. Liferidge, Thomas Andrew Windsor, Michael D. Witting · 2013 · Journal of Emergency Medicine
92. Progressive multifocal leukoencephalopathy and multiple sclerosis: Lessons from natalizumab
    Annette Magdalene Langer-Gould, Lawrence Steinman · 2006 · Current Neurology and Neuroscience Reports
93. Visual loss
    Grant T. Liu, Nicholas J. Volpe, Steven L. Galetta · 2010 · Elsevier eBooks
94. Mediators of apoptosis Fas and FasL predict disability progression in multiple sclerosis over a period of 10 years
    Luba Lopatinskaya, Jack Zwemmer, Bernard M.J. Uitdehaag, Kees Lucas, Chris H. Polman, Lex M. Nagelkerken · 2006 · Multiple Sclerosis Journal
95. Diagnosis and management of spinal cord emergencies
    Eoin P. Flanagan, Sean Joseph Pittock · 2017 · Handbook of clinical neurology
96. Preferences, Adherence, and Satisfaction: Three Years of Treatment Experiences of People with Multiple Sclerosis
    Olaf Martin Hoffmann, Friedemann Paul, Rocco Haase, Raimar Kern, Tjalf Ziemssen · 2024 · Patient Preference and Adherence
97. Recomendaciones para la utilización e interpretación de los estudios de resonancia magnética en la esclerosis múltiple
    Àlex Rovira, Mar Tintoré, Jose Carlos Alvarez-Cermeño, Guillermo Izquierdo, José María Laso Prieto · 2010 · Neurología
98. Role of IL-17-producing lymphocytes in severity of multiple sclerosis upon natalizumab treatment
    Ulrike Bühler, Vinzenz Fleischer, Felix Luessi, Ayman Rezk, Patrick Belikan, Christiane Graetz, René Gollan, Christina Wolf, Jens Lutz, Amit Bar‐Or et al. · 2016 · Multiple Sclerosis Journal
99. Multiple sclerosis
    Massimo Filippi, Paolo Preziosa, Maria Assunta Rocca · 2016 · Handbook of clinical neurology
100. Brain MRI findings in long-standing and disabling multiple sclerosis in 84 patients
     Dimitri Renard, Giovanni Castelnovo, Philippe‐Jean Bousquet, Nicolas Menjot de Champfleur, Jerome De Seze, Patrick Vermersch, Pierre M. Labauge · 2010 · Clinical Neurology and Neurosurgery